Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Expensive Performer
1419.0000 -26.70 (-1.85%)
NSE Apr 25, 2025 15:31 PM
Volume: 136.1K
 

1419.00
-1.85%
Karvy
Margin improvement due to product mix and lower overheads: In Q4FY19, total revenues of IPCA Labs increased by 7%YoY to Rs 8338 mn (our estimates Rs 8706 mn) mainly due to increase in domestic formulations and API.
Ipca Laboratories Ltd. is trading below its 100 day SMA of 1482.5
More from Ipca Laboratories Ltd.
Recommended